SCHEMBL21780072

SCHEMBL21780072

CC1COC2Cn3cc(Br)c(=O)c(OCc4ccccc4)c3C(=O)N12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.36
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
HTT P42858 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
GLRA1 P23415 1/20 0.33
TP53 P04637 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
S1PR5 Q9H228 1/20 0.32
SLC22A2 O15244 1/20 0.32
MAPK14 Q16539 2/20 0.31
NPC1 O15118 1/20 0.31
ABCB1 P08183 1/20 0.31
DHODH Q02127 1/20 0.31
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2161654 1.00 GRM2 (0.36) GRM2THRATHRBSMN1; SMN2HTT
SCHEMBL12239930 0.90 SLC22A2 (0.41) GRM2THRATHRBSMN1; SMN2HTT
SCHEMBL2296155 0.90 SLC22A2 (0.41) GRM2THRATHRBSMN1; SMN2HTT
SCHEMBL26727074 0.89 THRA (0.33) GRM2THRATHRBSMN1; SMN2HTT
SCHEMBL24969604 0.86 SLC22A2 (0.39) GRM2GLRA1LMNAS1PR5SLC22A2
SCHEMBL24969606 0.84 SLC22A2 (0.41) GRM2THRBHTTMEN1ALDH1A1
SCHEMBL2160801 0.82 HTT (0.42) GRM2SMN1; SMN2HTTMEN1ALDH1A1
SCHEMBL21780155 0.82 HTT (0.42) GRM2SMN1; SMN2HTTMEN1ALDH1A1
SCHEMBL12263528 0.82 THRA (0.32) THRATHRBALDH1A1SLC22A2
SCHEMBL26727070 0.80 GRM2 (0.33) GRM2THRATHRBSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3617194-A1 PROCESSES AND INTERMEDIATES FOR CARBAMOYLPYRIDONE HIV INTEGRASE INHIBITORS VIIV Healthcare Company (US) 2020-03-04 EP disclosed